Your session is about to expire
← Back to Search
Robotic Controllers for Motor Learning After Neurological Injuries (HRCEML Trial)
N/A
Recruiting
Led By Jose Pons, Ph.D
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No history of a brain and/or skull lesion
Normal hearing and vision, can be corrected
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in score at baseline, midpoint of intervention after 10 training sessions with assistive robot, and endpoint after 10 additional training sessions with the other assistive robot through participant completion, an average of 5 months.
Awards & highlights
Summary
This trial is looking at how humans physically interact with each other and how that might help develop robot controllers that can exhibit human-like behavior.
Who is the study for?
This trial is for individuals aged 18-80 with normal hearing and vision, who can understand English and give informed consent. It's suitable for healthy participants as well as those post-stroke or with spinal cord injury (SCI), provided they can walk over 10m independently. People with brain lesions, neurological disorders, abnormal limb movements, or outside the height range of 3'6" to 6'2" cannot join.
What is being tested?
The study aims to develop robot controllers that mimic human behavior in physical interactions. These will be tested on single joint (ankle) and multi-joint (ankle, knee, hip) robots using variable haptic behaviors like collaboration and competition to enhance motor learning in humans.
What are the potential side effects?
Since this trial involves behavioral interaction conditions rather than medical interventions or drugs, traditional side effects are not applicable. However, there may be fatigue or discomfort from interacting with the robotic devices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have never had a brain or skull lesion.
Select...
My hearing and vision are normal or corrected to normal.
Select...
I am between 18 and 80 years old.
Select...
I don't have conditions that cause abnormal limb movements.
Select...
I do not have any neurological disorders.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in score at baseline, midpoint of intervention after 10 training sessions with assistive robot, and endpoint after 10 additional training sessions with the other assistive robot through participant completion, an average of 5 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in score at baseline, midpoint of intervention after 10 training sessions with assistive robot, and endpoint after 10 additional training sessions with the other assistive robot through participant completion, an average of 5 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in lower limb motor control.
Change in motor output from surface EMG of lower limb muscles
Secondary study objectives
Change in 10 meter walking test.
Change in 6 minute walking test.
Change in BERG balance scale (BBS)
+8 moreTrial Design
4Treatment groups
Experimental Treatment
Group I: Healthy Participants Bilateral Lower Limb Exoskeleton (H3/X2)Experimental Treatment3 Interventions
The investigators will look at how the task performance and motor performance of individuals in dyadic physical interactions are affected.
Group II: Healthy Participants Ankle Robot (M1)Experimental Treatment3 Interventions
The investigators will look at how the task performance and motor performance of individuals in dyadic physical interactions are affected.
Group III: Clinical Populations Bilateral Lower Limb Exoskeleton (H3/X2)Experimental Treatment4 Interventions
The investigators will look at how the task performance and motor performance of individuals in dyadic physical interactions are affected.
Group IV: Clinical Populations Ankle Robot (M1)Experimental Treatment4 Interventions
The investigators will look at how the task performance and motor performance of individuals in dyadic physical interactions are affected.
Find a Location
Who is running the clinical trial?
U.S. National Science FoundationFED
34 Previous Clinical Trials
8,327 Total Patients Enrolled
2 Trials studying Stroke
12 Patients Enrolled for Stroke
Shirley Ryan AbilityLabLead Sponsor
204 Previous Clinical Trials
17,075 Total Patients Enrolled
71 Trials studying Stroke
7,877 Patients Enrolled for Stroke
Jose Pons, Ph.DPrincipal Investigator - Shirley Ryan AbilityLab
Shirley Ryan AbilityLab
1 Previous Clinical Trials
180 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had a stroke more than 6 months ago.I can walk more than 10 meters by myself, even with help from devices.I have never had a brain or skull lesion.My hearing and vision are normal or corrected to normal.I understand the study and agree to participate.I am between 18 and 80 years old.I don't have conditions that cause abnormal limb movements.I do not have any neurological disorders.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy Participants Ankle Robot (M1)
- Group 2: Clinical Populations Ankle Robot (M1)
- Group 3: Clinical Populations Bilateral Lower Limb Exoskeleton (H3/X2)
- Group 4: Healthy Participants Bilateral Lower Limb Exoskeleton (H3/X2)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Share this study with friends
Copy Link
Messenger